StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)

Close on Nov 17, 2026Market cap $545.36KP/E –Yield –

Clearmind Medicine price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Clearmind Medicine

Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Clearmind Medicine figures

See a number that looks wrong?